Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs in COVID-19
NCT04437823Phase 2Completed
- Sponsor
- Jinnah Hospital
- Start
- Jun 2020
- Primary completion
- Oct 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in coronavirus disease 2019 (COVID-19), sponsored by Jinnah Hospital. Started Jun 2020; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04437823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437823.